Literature DB >> 25212417

Disastrous Portal Vein Embolization Turned into a Successful Intervention.

Tomas Dobrocky1, Joachim Kettenbach2, Ruben Lopez-Benitez3, Levent Kara4.   

Abstract

Portal vein embolization (PVE) may be performed before hemihepatectomy to increase the volume of future liver remnant (FLR) and to reduce the risk of postoperative liver insufficiency. We report the case of a 71-year-old patient with hilar cholangiocarcinoma undergoing PVE with access from the right portal vein using a mixture of n-butyl-2-cyanoacrylate and ethiodized oil. During the procedure, nontarget embolization of the left portal vein occurred. An aspiration maneuver of the polymerized plug failed; however, the embolus obstructing portal venous flow in the FLR was successfully relocated into the right portal vein while carefully bypassing the plug with a balloon catheter, inflating the balloon, and pulling the plug into the main right portal vein.

Entities:  

Keywords:  Adverse effect; Cyanoacrylate; Embolization; Ethiodized oil; Hepatectomy; Portal vein

Mesh:

Year:  2014        PMID: 25212417     DOI: 10.1007/s00270-014-0985-z

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  2 in total

1.  Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n-butyl-cyanoacrylate.

Authors:  Romain Breguet; Sana Boudabbous; Lawrence F Pupulim; Christoph D Becker; Laura Rubbia-Brandt; Christian Toso; Maxime Ronot; Sylvain Terraz
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

2.  Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients.

Authors:  José Hugo Mendes Luz; Paula Mendes Luz; Tiago Bilhim; Henrique Salas Martin; Hugo Rodrigues Gouveia; Élia Coimbra; Filipe Veloso Gomes; Roberto Romulo Souza; Igor Murad Faria; Tiago Nepomuceno de Miranda
Journal:  Cancer Imaging       Date:  2017-09-20       Impact factor: 3.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.